Delivery Order SPE2DB24D2013-SPE2DB24FCGRZ
Award Date
4/18/24
Potential Completion Date
4/19/24
Potential Value
$23K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,366.13 firm fixed-price delivery order is for the supply of 4,563,851,552 units of Bupropion HCL XL 150 mg tablets. The contract has an ultimate completion date of March 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 4,564,543,508 units of Bupropion HCL XL 300 mg tablets. The contract has a ceiling value of $13,933.62 and is a firm fixed-price delivery order that will run through May 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through...
This federal contract award was issued by the U.S. Department of Defense's Medical Supply Chain agency to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Bupropion HCL XL 300 mg tablets. The firm-fixed-price delivery order, valued at $44,120.07, has an ultimate completion date of April 23, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,564,460 units of Bupropion HCL XL 150 mg tablets. The $59,427.55 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 2, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical valued at $13,969.24. The contract provides for the delivery of 4,564,110 units of Bupropion HCl XL 150 mg tablets by March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, is a delivery order for Bupropion HCL XL 150 mg tablets worth $8,900.78. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $4,863.34 firm fixed price delivery order contract for the supply of 4,564,029,023 units of Bupropion HCL XL 150 mg tablets. The contract has a period of performance through March 21, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and has an existing $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,368.94 firm fixed-price delivery order covers the supply of 4563862693 bupropion HCL XL 150 mg tablets to support military healthcare programs. The contract has a period of performance through March 6, 2024 and was not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,384.18 Firm Fixed Price Delivery Order contract is for the provision of 4567363926 - BUPROPION HCL XL 300 MG TABLET 500S. The contract has an ultimate completion date of February 25, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 500 tablets of Bupropion HCL XL 150 mg. The contract has a total potential value of $2,209.29 and a completion date of February 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 and running through...